SAN MARINO, Calif.--(BUSINESS WIRE)--Biotech company Viral Genetics, Inc., (Pinksheets: VRAL) has granted a renowned London research team the right to investigate its HIV/AIDS drug compound. The team is lead by scientist Dr. Robin Shattock.
SAN MARINO, Calif.--(BUSINESS WIRE)--Biotech company Viral Genetics, Inc., (Pinksheets: VRAL) has granted a renowned London research team the right to investigate its HIV/AIDS drug compound. The team is lead by scientist Dr. Robin Shattock.
